Passa al contenuto
Merck

Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features.

Clinical toxicology (Philadelphia, Pa.) (2014-10-28)
Sergey Zakharov, Daniela Pelclova, Pavel Urban, Tomas Navratil, Pavel Diblik, Pavel Kuthan, Jaroslav A Hubacek, Michal Miovsky, Jiri Klempir, Manuela Vaneckova, Zdenek Seidl, Alexander Pilin, Zdenka Fenclova, Vit Petrik, Katerina Kotikova, Olga Nurieva, Petr Ridzon, Jan Rulisek, Martin Komarc, Knut Erik Hovda
ABSTRACT

Methanol poisonings occur frequently globally, but reports of larger outbreaks where complete clinical and laboratory data are reported remain scarce. The objective of the present study was to report the data from the mass methanol poisoning in the Czech Republic in 2012 addressing the general epidemiology, treatment, and outcomes, and to present a protocol for the use of fomepizole ensuring that the antidote was provided to the most severely poisoned patients in the critical phase. A combined prospective and retrospective case series study of 121 patients with confirmed methanol poisoning. From a total of 121 intoxicated subjects, 20 died outside the hospital and 101 were hospitalized. Among them, 60 survived without, and 20 with visual/CNS sequelae, whereas 21 patients died. The total and hospital mortality rates were 34% and 21%, respectively. Multivariate regression analysis found pH < 7.0 (OR 0.04 (0.01-0.16), p < 0.001), negative serum ethanol (OR 0.08 (0.02-0.37), p < 0.001), and coma on admission (OR 29.4 (10.2-84.6), p < 0.001) to be the only independent parameters predicting death. Continuous hemodialysis was used more often than intermittent hemodialysis, but there was no significant difference in mortality rate between the two [29% (n = 45) vs 17% (n = 30), p = 0.23]. Due to limited stockpiles of fomepizole, ethanol was administered more often; no difference in mortality rate was found between the two [16% (n = 70) vs. 24% (n = 21), p = 0.39]. The effect of folate administration both on the mortality rate and on the probability of visual sequelae was not significant (both p > 0.05). Severity of metabolic acidosis, state of consciousness, and serum ethanol on admission were the only significant parameters associated with mortality. The type of dialysis or antidote did not appear to affect mortality. Recommendations that were issued for hospital triage of fomepizole administration allowed conservation of valuable antidote in this massive poisoning outbreak for those patients most in need.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Metanolo, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
Metanolo, HPLC Plus, ≥99.9%
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, meets USP testing specifications
Sigma-Aldrich
Ethyl alcohol, Pure 190 proof, for molecular biology
Sigma-Aldrich
Metanolo, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
Metanolo, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
Sodium formate, ACS reagent, ≥99.0%
Sigma-Aldrich
Metanolo, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
Etanolo, BioUltra, Molecular Biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Sigma-Aldrich
Metanolo, Absolute - Acetone free
Sigma-Aldrich
β-Dinucleotide nicotinamide adenina, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
USP
Metanolo, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Metanolo, BioReagent, ≥99.93%
Supelco
Etanolo, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Metanolo, analytical standard
Supelco
Etanolo, standard for GC
Sigma-Aldrich
Etanolo, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Supelco
Metanolo, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
β-Dinucleotide nicotinamide adenina, ≥95% (HPLC)
Sigma-Aldrich
β-Dinucleotide nicotinamide adenina, ≥99%
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Sigma-Aldrich
Sodium formate, reagent grade, 97%
Sigma-Aldrich
β-Dinucleotide nicotinamide adenina, suitable for cell culture, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Supelco
Ethanol-50, 50 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
Supelco
Ethanol-300, 300 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
Sigma-Aldrich
β-Dinucleotide nicotinamide adenina, Grade AA-1
Sigma-Aldrich
Reagent Alcohol, anhydrous, ≤0.003% water